Product Information
MEDROXYPROGESTERONE 150 MG/ML is a generic product labeled by Amphastar Pharmaceuticals, Inc., priced at $27.3638 per ML under NDC 00548570100. Its NADAC has been published 450 times since Feb 21, 2018.
FDA first approved this application on Nov 28, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
150 mg/mL
Manufacturer
Amphastar Pharmaceuticals, Inc.NDC
00548570100
Classification
Generic
Dosage Form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
Generic (ANDA)
FDA Application
ANDA077334FDA Approved
11/28/2017
TE Code
AB
On Market Since
11/28/2017
Pharmacological Classes
Price Statistics
The NADAC for MEDROXYPROGESTERONE 150 MG/ML has been published 450 times since Feb 21, 2018, and over the history we have for it it has declined 66.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $27.3638 per ML |
|---|---|
| All-time high | $82.4805 (Apr 11, 2018) |
| All-time low | $25.6030 (May 20, 2026) |
| 52-week high | $33.1451 |
| 52-week low | $25.6030 |
| Median price | $43.7877 |
| Average price | $46.0632 |
| Largest weekly change | +39.7% (Aug 21, 2024) |
| Weeks tracked | 450 |
| Tracking since | Feb 21, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amphastar Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Medroxyprogesterone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEDROXYPROGESTERONE 150 MG/ML?
The current National Average Drug Acquisition Cost (NADAC) for MEDROXYPROGESTERONE 150 MG/ML, manufactured by Amphastar Pharmaceuticals, Inc., is $27.3638 per ML (NDC 00548570100), effective Sep 30, 2026.
How has the price of MEDROXYPROGESTERONE 150 MG/ML changed over time?
Over the history we have for it, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has declined 66.7%. It has been tracked across 450 weekly CMS publications since Feb 21, 2018.
What are the highest and lowest recorded NADAC prices for MEDROXYPROGESTERONE 150 MG/ML?
Since Feb 21, 2018, the NADAC for MEDROXYPROGESTERONE 150 MG/ML has ranged from a low of $25.6030 (May 20, 2026) to a high of $82.4805 (Apr 11, 2018), with a median of $43.7877 per ML.
Are there cheaper alternatives to MEDROXYPROGESTERONE 150 MG/ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MEDROXYPROGESTERONE 150 MG/ML, is $18.8535 per ML — about 31% below MEDROXYPROGESTERONE 150 MG/ML.
Who manufactures MEDROXYPROGESTERONE 150 MG/ML?
MEDROXYPROGESTERONE 150 MG/ML (NDC 00548570100) is labeled by Amphastar Pharmaceuticals, Inc., and CMS classifies it as a generic product.